[1] WHO. Frequently asked questions[EB/OL].(2011-07-19)[2017-03-06]. http://www.who.int/medicines/services/counterfeit/faqs/QandAsUpdateJuly11.pdf?ua=1. [2] Khan A N, Khar R K.Current scenario of spurious and substandard medicines in India: A systematic review[J]. Indian Journal of Pharmaceutical Sciences, 2015. 77(1): 2-7. [3] 冯红云,杨乐,宋秋洁,等.建设基于药品不良反应监测的聚集性不良事件预警体系的设想和实践[J].中国药物警戒, 2015(11): 665-668. [4] Trippe Z A, Brendani B, Meier C, et al.Identification of Substandard Medicines via Dispropor-tionality Analysis of Individual Case Safety Reports[J]. Drug Safety, 2017. 40(4): 293-303. [5] 史文涛,叶小飞,张天一,等.不相称测定分析中存在的问题及分析策略[J].药物流行病学,2014(07): 437-440. [6] 史文涛,侯永芳,叶小飞,等.我国药品不良反应自发呈报系统中信号强度分级阈值的探索[J]. 药物流行病学, 2015(08): 466-469. [7] Juhlin K,Karim G, Ande'r M, et al.Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites[J]. Drug Safety, 2015. 38(4): 373-382. [8] DuMouchel W, Yuen N, Payvandi N, et al.Automated Method for Detecting Increases in Frequency of Spontaneous Adverse Event Reports over Time[J]. Journal of Biopharmaceutical Statistics, 2013,23(1): 161-177. [9] Chambers J, Cleveland W, Kleiner B, et al.Graphical Methods for DataAnalysis[M]. Belmont, CA: Wadsworth,1983. [10] 任经天,王胜锋,侯永芳,等.常用药品不良反应信号检测方法介绍[J].中国药物警戒, 2011(5): 294-298. [11] 冯变玲,杨世民,兰夏璐,等.心脑血管疾病用药不良反应与药品品种关系的聚类分析[J].中国药业, 2011(6): 17-18. [12] 路长飞,田月洁.基于盐酸克林霉素注射剂不良反应监测数据探索聚类分析方法在药品不良反应监测中的应用[J].中国药物警戒, 2014(1): 27-30, 34. [13] 冯红云,侯永芳,吴桂芝,等.药品不良事件聚集性信号预警系统的建立和运行[J].中国药物警戒, 2012(12): 745-747. [14] 冯红云,葛文超,夏旭东,等.聚集性药品不良事件预警系统共享平台的建设和实践[J].中国药物警戒, 2015(12): 727-730. [15] YLiu,P Lependu,S Iyer,et al.Using Temporal Patterns in Medical Records to Discern Adverse Drug Events from Indications[J].Amia Joint Summits on Translational Science Proceedings Amia Joint Summits on Translational Science,2012, 2012 (1) :47. |